A 96 Well Microtiter Plate-based Method for Monitoring Formation and Antifungal Susceptibility Testing of Candida albicans Biofilms
- 21 October 2010
- journal article
- video audio-media
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 44,p. e2287
- https://doi.org/10.3791/2287
Abstract
Candida albicans remains the most frequent cause of fungal infections in an expanding population of compromised patients and candidiasis is now the third most common infection in US hospitals. Different manifestations of candidiasis are associated with biofilm formation, both on host tissues and/or medical devices (i.e. catheters). Biofilm formation carries negative clinical implications, as cells within the biofilms are protected from host immune responses and from the action of antifungals. We have developed a simple, fast and robust in vitro model for the formation of C. albicans biofilms using 96 well microtiter-plates, which can also be used for biofilm antifungal susceptibility testing. The readout of this assay is colorimetric, based on the reduction of XTT (a tetrazolium salt) by metabolically active fungal biofilm cells. A typical experiment takes approximately 24 h for biofilm formation, with an additional 24 h for antifungal susceptibility testing. Because of its simplicity and the use of commonly available laboratory materials and equipment, this technique democratizes biofilm research and represents an important step towards the standardization of antifungal susceptibility testing of fungal biofilms.Keywords
This publication has 12 references indexed in Scilit:
- Candida albicans biofilm development, modeling a host–pathogen interactionCurrent Opinion in Microbiology, 2006
- Regulation of Cell-Surface Genes and Biofilm Formation by the C. albicans Transcription Factor Bcr1pCurrent Biology, 2005
- CandidaBiofilms: an UpdateEukaryotic Cell, 2005
- Antifungal Combinations against Candida albicans Biofilms In VitroAntimicrobial Agents and Chemotherapy, 2003
- Uses and Limitations of the XTT Assay in Studies of Candida Growth and MetabolismJournal of Clinical Microbiology, 2003
- In Vitro Pharmacodynamic Properties of Three Antifungal Agents against PreformedCandida albicansBiofilms Determined by Time-Kill StudiesAntimicrobial Agents and Chemotherapy, 2002
- Characteristics of biofilm formation by Candida albicans.2001
- Standardized Method for In Vitro Antifungal Susceptibility Testing of Candida albicans BiofilmsAntimicrobial Agents and Chemotherapy, 2001
- Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents.1998
- Innovative endpoint determination system for antifungal susceptibility testing of yeastsAntimicrobial Agents and Chemotherapy, 1992